Clinical study to Evaluate the efficacy of Shatavari-Madhuk Siddha ghrita Tarpan and Abhyantarsevan to reduce the ill effects of extensive use of small scree
Phase 1
- Conditions
- Health Condition 1: H578- Other specified disorders of eye and adnexa
- Registration Number
- CTRI/2023/08/056518
- Lead Sponsor
- Dr Ashwini Sayabu Gaikwad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient suffering from small screen addiction and having at least 3 classical symptoms e.g. Rukshvartmakshi, Darunvartma, Kunitavartma , Avil darshnam , Kruchchhonmilata
Patient using screen more than 2 to 3.6hr/day
Exclusion Criteria
Cases where surgical intervention is required
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of Shatavari-Madhuk siddha ghrita Tarpan and Abhyantarpan to reduce the ill effects of extensive use of small screen (Both root drug result is better than single root)Timepoint: Period â?? <br/ ><br>Session 1 â?? Day 1st to 5th Tarpan given to patient 5 day, then a gap for 10 days <br/ ><br>Session 2 - Day 16th to 20th Tarpan given to patient 5 day , then a gap for 10 days <br/ ><br>Session 3- Day 31st to 35th Tarpan given to patient 5 day,then a gap for 10 days <br/ ><br>Time â?? Tarpan 30 minutes both eyes <br/ ><br>Dose â?? Tarpan ghrita 100ml ( 50 ml each eye) <br/ ><br>
- Secondary Outcome Measures
Name Time Method Adverse Reaction if anyTimepoint: 45 days